FDG-PET in the management of germ cell tumor.
Germ cell tumor is the most common malignancy in young men. The cure rate of these patients has tremendously increased in the cisplatin era, and recent results have indicated that the management of patients with GCT is still improving. The use of FDG-PET in the management of patients with GCT has been recently investigated. This report attempts to comprehensively review new advances and delineate the potential applications of FDG-PET in GCT.
De Giorgi
U
U
Istituto Toscano Tumori, Department of Oncology, San Giuseppe Hospital, Empoli Florence, Italy. ugo_degiorgi@yahoo.com
Pupi
A
A
Fiorentini
G
G
Rosti
G
G
Marangolo
M
M
D000328:Adult; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008479:Mediastinal Neoplasms / Q000000981:diagnostic imaging*; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D009367:Neoplasm Staging / Q000379:methods; D018365:Neoplasm, Residual; D009373:Neoplasms, Germ Cell and Embryonal / Q000000981:diagnostic imaging* / Q000556:secondary; D049268:Positron-Emission Tomography; D011237:Predictive Value of Tests; D012186:Retroperitoneal Neoplasms / Q000000981:diagnostic imaging*; D013736:Testicular Neoplasms / Q000000981:diagnostic imaging*; D016896:Treatment Outcome
D019788:Fluorodeoxyglucose F18